Pharmaceutical Technology

SEPTEMBER 9, 2022

US-based biotech company Gatehouse Bio is extending its collaboration with AstraZeneca for developing RNA therapeutics to treat heart failure with preserved ejection fraction (HFpEF). It is expected to expedite the development of a wide range of new therapeutics using the small non-coding area of the genome that is not explored.

RNA 246

RNA Development Gene Therapy Gene 246

AuroBlog - Aurous Healthcare Clinical Trials blog

NOVEMBER 1, 2022

As drug companies have embarked on an initiative to launch affordable medicines for rare diseases in India, experts have called for using pharmacogenetics to develop treatments and whole genome sequencing to identify etiologies.

Development 189

Development Genome Genomics Medicine 189

Pharmaceutical Technology

SEPTEMBER 1, 2022

Guardant Health has extended a partnership with Merck KGaA, Darmstadt, Germany, to aid in expediting precision oncology therapeutics development. Under the collaboration, the companies will use the GuardantINFORM real-world evidence (RWE) platform to boost works for developing Merck’s precision cancer pipeline.

Development 162

Development Genome Genomics Medicine 162

Pharmaceutical Technology

FEBRUARY 19, 2025

A team of scientists has developed a new AI-based foundation model that can give insights into disease-causing mutations and genome design.

Scientist 147

Scientist Development Genome Genomics 147

XTalks

APRIL 21, 2023

The application of whole genome sequencing (WGS) to derive a more complete understanding of cancer has been a central goal of cancer researchers even before the first human genome was decoded in 2003. Ultima Genomics has already partnered with other leading biotech startups.

Genomics 97

Genomics Genome Bioinformatics Genetics 97

pharmaphorum

JANUARY 26, 2023

2022 was a banner year for genomics. In March, the collaborative T2T consortium published the first complete telomere-to-telomere sequence of the human genome, filling in the last 8% of the 3 billion base pairs that make up our DNA.

Genomics 129

Genomics Genome Genome Project Genetics 129

pharmaphorum

SEPTEMBER 14, 2020

Here he gives us a deeper look at how genomic medicine is evolving and the barriers that are preventing it from reaching its full potential. I saw this, in particular, with the finishing of the human genome,” says Charlie. “At In reality, finishing the human genome was the first step of what is a long journey.”.

Genomics 119

Genomics Genome Medicine Gene 119

Pharmaceutical Technology

NOVEMBER 5, 2024

This initiative brings together UK Biobank, Genomics England, NHS England, and Oxford Nanopore to accelerate genomics-based research in the UK.

Biobanking 147

Biobanking Genome Genomics Development 147

Pharmaceutical Technology

JUNE 30, 2022

Analysing almost eight thousand tumours across 33 different cancers, researchers say this marks the first time that a framework was created to understand the role of internal factors in driving such genomic alterations. Genomic research have greatly expanded our understanding of disease pathophysiology over the years.

Genome Project 130

Genome Project Genomics Genome DNA 130

Pharmaceutical Technology

AUGUST 7, 2024

Sangamo Therapeutics has signed an agreement with Genentech for the development of genomic medicines to treat neurodegenerative diseases.

Development 130

Development Genome Genomics Medicine 130

pharmaphorum

OCTOBER 16, 2024

The pandemic served as a catalyst for a revolution in genomic surveillance for tracking pathogens. The technology proved vital in aiding understanding of the evolution of and spread of virus in real time to inform public health measures, ultimately accelerating drug and vaccine development.

Genomics 115

Genomics Genome Vaccination Vaccine 115

pharmaphorum

NOVEMBER 10, 2024

Recent funding rounds in the digital health arena feature digital pathology startup Aignostics, remote care specialists TCC, Yazen Health, and Nema Health, wearables developer Alimetry, and clinical trial automation startup Research Grid.Digital pathology specialist Aignostics, which develops artificial intelligence algorithms to glean information (..)

Genome 110

Genome Genomics Clinical Trials Clinical Trials 110

Camargo

NOVEMBER 11, 2020

Each month, Camargo’s “In the News” series highlights important changes and advancements in the regulatory and development space and explores how those changes could impact your program. Still, navigating such patent issues during drug development can be difficult, and Camargo can assist in finding a safe course. Ken Phelps.

Development 242

Development Bioequivalency Generic Drugs Production 242

BioSpace

AUGUST 30, 2020

When Bionano Genomics acquired Lineagen, Inc. in August, the genomic analysis company gained the final piece it needed to provide comprehensive structural variation detection for researchers and drug developers and a reimbursement pathway for clinicians who want to use its technology to replace c.

Genomics 120

Genomics Genome Development Drugs 120

Pharmaceutical Technology

JULY 26, 2022

The last few months have marked the publication of research emerging from projects designed to collect and analyse genomic data on a wider scale than was previously thought possible. The post Magazine: Genomic projects exploit scale as clinical applications play catch-up appeared first on Pharmaceutical Technology.

Genome Project 130

Genome Project Genomics Genome Clinical Trials 130

pharmaphorum

OCTOBER 31, 2022

Verge Genomics has joined a select group of biotechs who have taken a drug discovered and developed using artificial intelligence into human testing. The post Verge Genomics takes AI-sourced drug for ALS into clinic appeared first on.

Genomics 136

Genomics Genome Drugs RNA 136

Pharma Mirror

OCTOBER 4, 2021

Open source drug discovery will allow more efficient, predicable, and cost-effective development of drugs that work as advertised, with fewer side effects. In 2003 the Human Genome Project provided the first atlas. The post Open Source “Wikipedia” for Drug Discovery appeared first on Pharma Mirror Magazine.

Genome Project 299

Genome Project Drugs FDA Approval Genome 299

pharmaphorum

JUNE 13, 2022

Canary Wharf’s bid to become a new hub for the life sciences sector in the UK has been given a boost following the decision by Genomics England to relocate to the development. ” The post Genomics England will move HQ to Canary Wharf’s new biocluster appeared first on. .

Genomics 111

Genomics Genome Life Science Genome Project 111

BioPharma Reporter

SEPTEMBER 12, 2023

Mission Bio, a leader in single-cell multi-omic solutions for precision medicine, has launched its new Tapestri Genome Editing Solution.

Genomics 124

Genomics Genome Medicine Development 124

Pharmaceutical Technology

SEPTEMBER 22, 2022

You have just received the results from your whole genome sequencing test, offered through your public health provider, and discovered that you have a 75% chance of developing a rare form of cancer. It is the year 2030. Alternatively, there are vaccines ready to enter decentralised third-phase clinical trials, so you can enrol quickly.

Genomics 342

Genomics Genome Clinical Trials Clinical Trials 342

Worldwide Clinical Trials

APRIL 7, 2025

This variability complicates eligible participant identification and the development of effective treatments, as traditional recruitment methods often result in slow enrollment and high screen-fail rates. Centralization establishes a uniform sample evaluation, reducing inter-site variability and improving data consistency.

Medicine 100

Medicine Research Clinical Trials Clinical Trials 100

Pharma Times

JANUARY 17, 2024

License agreement concerns development of cell therapies for corneal blindness

Genomics 150

Genomics Genome Licensing Licensing 150

Drug Discovery Today

OCTOBER 27, 2022

The country now hosts the EMBL Partnership Institute for Genome Editing Technologies at the Vilnius University Life Sciences Center aiming to advance gene editing technologies. Lab, focused on research and development of novel genome editing tools. One of them is the Jones!Lab,

Genomics 85

Genomics Genome Gene Editing Life Science 85

Pharmaceutical Technology

JUNE 16, 2023

Benefiting from Abu Dhabi’s improved genomics capabilities, the deal seeks to expand research into genomic medicine and genetic diseases to provide patients in the UAE and beyond with improved access to new tools and treatments.

Life Science 130

Life Science Genetic Disease Genome Genomics 130

pharmaphorum

MARCH 12, 2021

The UK regulator has authorised Eli Lilly’s targeted cancer drug Retsevmo for tumours with RET fusion positive lung cancers and thyroid cancers, which the company said could herald a new era of genomic medicine for the NHS. billion collaboration with Bluebird Medicines to develop a rival RET inhibitor, pralsetinib.

Genomics 111

Genomics Genome Medicine Regulation 111

pharmaphorum

SEPTEMBER 12, 2022

Alongside drugs and therapeutics, data collection and technology enhancements have redefined the traditional healthcare experience, especially within oncology, and genomic profiling has become a significant factor in allowing for personalised care. Tailored oncology. In other words, every person’s cancer has its own genetic construct.

Genomics 105

Genomics Genome Clinical Trials Clinical Trials 105

STAT News

AUGUST 17, 2022

When the Smithsonian National Museum of Natural History opened its genomics exhibit in 2013, the field was just celebrating the 10th anniversary of the completed Human Genome Project. Sequencing that first genome cost over $500 million. The genomes since cost $10,000. The development of CRISPR-Cas9 landed a Nobel Prize.

Genomics 98

Genomics Genome Genome Project DNA 98

pharmaphorum

NOVEMBER 27, 2022

A group representing pharma companies selling precision therapies for cancer has called for a change to the way genomic testing is done in Scotland, to make sure patients get access to targeted drugs. The post Genomic testing ‘should be offered to all cancer patients in Scotland’ appeared first on. Why not lead?”

Genomics 104

Genomics Genome Genetics Medicine 104

Camargo

DECEMBER 10, 2021

Each month, Camargo’s “In the News” series highlights important changes and advancements in the regulatory and development space and explores how those changes could impact your program. Voxzogo Approved as a Growth-Improvement Therapy for Children with Dwarfism.

Development 176

Development Genetics Production Clinical Trials 176

XTalks

MARCH 1, 2024

In a pivotal move for the food industry, the US Food and Drug Administration (FDA) has unveiled industry guidance for genome edited foods derived from plants. This landmark guidance aims to demystify the FDA’s risk-based approach towards both genome edited foods and all new plant varieties. What is Genome Editing?

Genomics 86

Genomics Genome Production Marketing 86

Scienmag

JULY 11, 2022

SAN DIEGO, Calif.

Genomics 83

Genomics Genome Medicine Drugs 83

Pharmaceutical Technology

SEPTEMBER 29, 2022

Scribe Therapeutics and Sanofi have signed a strategic partnership to expedite the development of breakthrough clustered regularly interspaced short palindromic repeats (CRISPR)-based cell therapies for cancer. Scribe is also entitled to receive potential payments worth over $1bn on meeting development and commercial milestones.

Development 130

Development In-Vivo Genomics Genome 130

AuroBlog - Aurous Healthcare Clinical Trials blog

OCTOBER 3, 2023

Indian medical devices companies are increasingly looking to invest in innovation for developing products that help to minimize environmental footprint.

Production 189

Production Genome Genomics Development 189

pharmaphorum

MARCH 17, 2025

Inaugural Dark Genome Target Discovery & Development Summit Sara.Scarpinati Mon, 17/03/2025 - 16:59 Bookmark this

Genomics 52

Genomics Genome Development 52

Pharmaceutical Technology

OCTOBER 11, 2022

Biotechnology company Ochre Bio has raised $30m in a Series A financing round to develop RNA therapies for chronic liver diseases. Ochre Bio will also expand its platforms for drug discovery and development that include a new RNA chemistry and an exploratory platform for expanding its research to more liver diseases.

RNA 130

RNA Development Genomics Genome 130

Pharmaceutical Technology

DECEMBER 14, 2022

GSK has entered a strategic partnership with Wave Life Sciences to progress the discovery and development of oligonucleotide therapies for new genetic targets. The alliance will merge the PRISM oligonucleotide platform of Wave and the capabilities of GSK in genetics and genomics.

Life Science 162

Life Science Development Gene Therapy Genetics 162

Pharmaceutical Technology

NOVEMBER 8, 2022

Fulgent Genetics has acquired clinical-stage therapeutics development firm Fulgent Pharma for a total deal price of nearly $100m. With the takeover, Fulgent Genetics intends to transform into a completely integrated precision medicine firm focusing on oncology from a genomic diagnostic business.

Genetics 130

Genetics Development Genomics Genome 130